#DRUG

Last 24h 📉 Bearish 📉1

Last 7 Days 📉 Bearish 📉1

Last 30 Days 📉 Bearish 📉1

News 📈 Stocks

Bright Minds Biosciences Shares Slide on FDA Partial Clinical Hold

November 3, 2026 (2 hours ago)

Bright Minds Biosciences stock faces downward pressure as the FDA halts its Phase 2 epilepsy trial due to toxicity concerns, prompting legal…

DRUG

🌍 AMERICAS Read More →